Histamine H4 receptor gene polymorphisms: a potential contributor to Meniere disease

Danxia Qin1, Han Zhang2, Jiehua Wang1

  • 1Inpatient Department 7th floor District 6, Dongjie Branch of Quanzhou 1st Hospital, Quanzhou 1st Hospital Affiliated to Fujian Medical University, Quanzhou, 362000, Fujian, China.

Abstract

Insights

Histamine H4 receptor gene variations may increase Meniere

Area of Science:

  • Immunology
  • Genetics
  • Otolaryngology

Background:

  • The immune system's role in Meniere's disease (MD) pathophysiology is suspected but not well-understood.
  • Histamine H4 receptors are highly expressed in immune cells, suggesting a potential link to MD.
  • Investigating histamine H4 receptor gene polymorphisms could reveal contributions to MD risk.

Purpose of the Study:

  • To test the hypothesis that histamine H4 receptor gene polymorphisms contribute to Meniere's disease risk.
  • To explore the association between a specific HRH4 gene polymorphism (rs77485247) and MD.
  • To investigate correlations between this polymorphism, vertigo symptoms, and proinflammatory cytokine levels in MD patients.

Main Methods:

  • Enrolled patients with definite Meniere's disease (MD) and a control group without vestibular disorders.
  • Selected a single nucleotide polymorphism (SNP), rs77485247, in the histamine H4 receptor (HRH4) gene.
  • Conducted exploratory analysis of correlations between the rs77485247 polymorphism, vertigo, and cytokine levels (IL-1β, TNF-α) in peripheral blood mononuclear cells (PBMCs).

Main Results:

  • The HRH4 rs77485247 polymorphism showed a potential association with Meniere's disease risk.
  • Patients with MD exhibited increased basal levels of proinflammatory cytokines (IL-1β, TNF-α) in PBMCs compared to controls.
  • Elevated cytokine levels were more pronounced in MD patients carrying the 'A' allele of the rs77485247 polymorphism.

Conclusions:

  • The HRH4 rs77485247 polymorphism may play a role in Meniere's disease pathogenesis.
  • This polymorphism might mediate the regulation of proinflammatory cytokines implicated in MD.
  • Further research is warranted to elucidate the specific mechanisms linking HRH4 genetics to MD.

Related Concept Videos

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
966
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.3K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.0K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
685
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
110.7K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K